Councils - Junior Faculty and Trainee



Scientific Council for Junior Faculty & Trainees



NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 11 Scientific Councils.




UPCOMING COUNCIL MEETING:
Thursday, April 28, 2016, 7:00 AM - 8:00 AM
in the Harding Room of the Marriott Wardman Park Hotel, Washington, DC, during the ISHLT 36th Annual Meeting and Scientific Sessions



INTERNATIONAL FELLOWSHIP DATABASE:

www.ishlt.org/councils/fellowshipDatabase.asp



LINKS NEWSLETTER:

Issues focusing on Junior Faculty and Trainees:

October 2015
July 2015
December 2014
June 2014: JFTC Report 2013-2014
December 2013
August 2013
May 2013: JFTC Year in Review
October 2012
March 2012




ISHLT MENTORSHIP PROGRAM:

The goal of the ISHLT Mentorship Program is to provide an opportunity for trainees to meet with an established specialist in their respective field in order to facilitate communication and gain guidance, and provide an opportunity for academic career enrichment.

The ISHLT Mentorship Program is now available to all ISHLT members via ISHLTConnect, our Online Community. (This program is only available to current ISHLT members.)

COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Keyur B. Shah, MD (2020)
Virginia Commonwealth University
Richmond, VA, USA
804-828-4571
kshah@mcvh-vcu.edu

Dr. Shah is an Assistant Professor  in the Division of Cardiology at Virginia Commonwealth University Hospital System (formerly Medical College of Virginia) in Richmond, VA. Dr. Shah completed both his residency in internal medicine and fellowship training at the University of Maryland, Baltimore, MD. Dr. Shah’s clinical interests include  heart failure, heart transplantation, pulmonary hypertension and mechanical circulatory support.  He is the Medical Director of the Mechanical Circulatory Support Program at VCU.


COUNCIL VICE CHAIR:

Evan P Kransdorf, MD, PhD (2022)
Cedars-Sinai Heart Institute
Los Angeles, CA, USA
Evan.Kransdorf@cshs.org

Evan Kransdorf received both MD and PhD degrees from the Virginia Commonwealth University School of Medicine in 2006.  His PhD is in Molecular Biology and Genetics. He then completed a residency in Internal Medicine at Duke University Medical Center followed by a fellowship in Advanced Heart Failure and Heart Transplantation at Cedars-Sinai Medical Center. He completed his training in cardiovascular diseases at Mayo Clinic Arizona in 2015. He is currently a heart failure and heart transplant cardiologist with the Cedars-SInai Heart Institute and Cedars-Sinai Medical Center. His main research focus is on the use of data science to improve clinical outcomes in heart failure and after heart transplantation.


COUNCIL PAST CHAIR:

Eugene C. DePasquale, MD (2018)
David Geffen School of Medicine
Los Angeles, California, USA
917-658-9086
edepasquale@mednet.ucla.edu

Dr. DePasquale received his M.D. degree from State University of New York, Downstate College of Medicine. He completed his Internal Medicine Residency, Fellowship in Cardiovascular Medicine, and a Fellowship in Advanced Heart Failure and Transplant Cardiology at the Yale-New Haven Hospital. At the same institution, he was Chief Cardiology Fellow, and completed an additional Fellowship with a focus in Inherited Cardiomyopathies with additional study at University College London. Dr. DePasquale currently serves as an Associate Director - Outpatient Heart Transplantation for the UCLA Advanced Heart Failure, Heart Transplantation and Mechanical Circulatory Support Programs.


BOARD OF DIRECTORS LIAISON:

Duane Davis, MD, MBA
Florida Hospital
Orlando, FL, USA
duane.davis@flhosp.org

Bio coming soon...

EDUCATION WORKFORCE LEADER:

Martin Schweiger, MD (2018)
Children's Hospital
Zurich, SWITZERLAND
43 664 3124611
martinschweig88@hotmail.com

Bio coming soon...

I2C2 WORKFORCE LEADER:

Hirsch S. Mehta, MD (2019)
San Diego Cardiac Center
San Diego, CA, USA
hirschmehta@gmail.com

Bio coming soon...

STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:


Jose Nativi, MD (2017)
University of Utah
Salt Lake City, UT, USA
jose.nativi@hsc.utah.edu

Bio coming soon....

LINKS NEWSLETTER LIAISON:

Jorge Silva Enciso, MD (2018)
University of California San Diego / UCSD Medical Center
San Diego, CA, USA
858-657-5359
jsilvaenciso@ucsd.edu

Dr. Silva Enciso is an Assistant Professor of Medicine in the Division of Cardiology at University of California San Diego. He completed his residency and Cardiovascular Disease Fellowship at St. Luke’s-Roosevelt Hospital center, NY, followed by Advanced Heart Failure Fellowship training at Columbia University Medical Center in 2011. In 2012 he joined as Faculty the Advanced Heart Failure Program at UC San Diego where he currently functions as the Advanced Heart Failure Fellowship Assistant Director. His interests focus on mechanical circulatory support, right ventricular dysfunction and cardiac transplantation.


LIAISONS TO OTHER COUNCILS:


BSTR COUNCIL LIAISON:

Simon Pecha, MD
University Hospital Hamburg
Hamburg, GERMANY
49-175-168-7526
s.pecha@uke.de

Bio coming soon...

HFTX COUNCIL LIAISON:

To Be Appointed

ID COUNCIL LIAISON:

Ignacio A Echenique, MD
Cleveland Clinic Florida
Weston, FL, USA
787-914-3291
ignacio.echenique@northwestern.edu

Bio coming soon...


MCS COUNCIL LIAISON:

Palak Shah, MD, MS
Inova Fairfax Hospital
Falls Church, Virginia, USA
703-776-7231
palak.shah@inova.org

Palak Shah, MD, MS is a researcher and transplant Cardiologist at Inova Fairfax Hospital.  Dr. Shah’s clinical interests include advanced cardiomyopathies, mechanical circulatory support and cardiac transplantation.  He received his undergraduate training from Carnegie Mellon University and medical degree from St. George’s University in 2005.  He subsequently completed residency in Internal Medicine at Georgetown University.  In 2009, he spent a year as Chief Medical Resident at Georgetown University. During his Cardiovascular Disease Fellowship at George Washington University he received a Masters in Clinical and Translational Research and was also elected into the Alpha Omega Alpha honors society.  Dr. Shah received his Heart Failure and Cardiac Transplant training at the University of Michigan in 2012.  His research interests are focused in mechanical circulatory support; more specifically use of genomic tools to better predict and manage the complications of VAD therapy.


PEDS COUNCIL LIAISON:

Chesney Castleberry, MD
Washington University St. Louis
St. Louis, MO, USA
Castleberry_C@kids.wustl.edu

Bio coming soon...

PH COUNCIL LIAISON:

Marco A. Caccamo, MD
Indiana University Health
Indianapolis, IN, USA
mcaccamo@iuhealth.org

Marco Caccamo, DO, is an Assistant Professor of Medicine at Indiana University School of Medicine. He completed his residency training at the Cleveland Clinic in 2009. Dr. Caccamo then moved to Minneapolis, Minnesota where he completed his cardiology training at the University of Minnesota in 2012. He then completed an additional year in advanced heart failure and pulmonary hypertension at Allegheny General Hospital in Pittsburgh, PA. His clinical interests include pulmonary hypertension, mechanical circulatory support and cardiac transplantation.



PULM TX COUNCIL LIAISON:

Robin Vos, MD, PhD
University Hospital Gasthuisberg
Leuven, BELGIUM
32-16-34-15-48
robin.vos@uz.kuleuven.be

Robin Vos, MD, PhD, is Assistant Professor of Pulmonary Medicine at the Katholieke Universiteit and University Hospital Gasthuisberg, Leuven, Belgium. He obtained his undergraduate degree in Medicine at the Faculty of Medicine, Katholieke Universiteit Leuven, Belgium in 2004, after which he completed his Residency in Internal and Pulmonary Medicine at the University Hospital Gasthuisberg, Leuven, Belgium in 2012. From 2006 until 2010 he performed his PhD fellowship in the lab of Pneumology, Katholieke Universiteit Leuven, Belgium under the supervision of Prof. dr. GM. Verleden. His clinical and research interests include the pathophysiology and treatment of acute and chronic lung allograft rejection.

Text SizeIncrease Font SizeDecrease Font Size